# Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients

> **NCT00157131** · PHASE3 · COMPLETED · sponsor: **Baxter Healthcare Corporation** · enrollment: 150 (actual)

## Conditions studied

- Deep Partial or Full Thickness Wounds

## Interventions

- **BIOLOGICAL:** Fibrin Sealant, ARTISS 4IU/ml VH SD
- **OTHER:** Staples

## Key facts

- **NCT ID:** NCT00157131
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2017-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00157131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00157131, "Safety and Efficacy Study of FS 4 IU VH S/D (Fibrin Sealant With 4IU/mL Thrombin, Vapor Heated, Solvent/Detergent Treated) to Adhere Split Thickness Skin Grafts and Improve Wound Healing in Burn Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00157131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*